Trial Profile
A phase II study of ANB019
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2017
Price :
$35
*
At a glance
- Drugs Imsidolimab (Primary)
- Indications Generalised pustular psoriasis
- Focus Therapeutic Use
- 08 Mar 2017 According to an AnaptysBio media release, this trial is expected to initiate during 2018.
- 17 Jul 2015 New trial record